GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
80 hedge funds and large institutions have $550M invested in GenMark Diagnostics, Inc in 2015 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 9 closing their positions.
42% more call options, than puts
Call options by funds: $92K | Put options by funds: $65K
13% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 24
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
1% more funds holding
Funds holding: 79 → 80 (+1)
5% less capital invested
Capital invested by funds: $579M → $550M (-$28.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$11.9M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$3.99M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.5M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.14M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$8.78M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$4.56M |
| 3 |
Parnassus Investments
San Francisco,
California
|
-$3.67M |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$3.47M |
| 5 |
JG
Jefferies Group
New York
|
-$2.6M |
GNMK Hedge Fund Activity: Q1 2015 in Review
80 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q1 2015, worth a combined $550M — down 5% from $579M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new GNMK positions and 9 closed out — a net gain of 1 holder — while 27 added to existing stakes and 24 trimmed.
The largest buyer was Fred Alger Management, opening a new position worth an estimated $11.9M. The largest seller was Visium Asset Management, cutting an estimated $8.78M.
- 80 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q1 2015, up from 79 in Q4 2014.
- Funds reported $550M of GenMark Diagnostics, Inc stock for Q1 2015, down 5% quarter-over-quarter.
- 10 funds opened new GenMark Diagnostics, Inc positions in Q1 2015 and 9 closed out, a net change of +1 holder.
- The largest GenMark Diagnostics, Inc buyer in Q1 2015 was Fred Alger Management, an estimated $11.9M added.
- The largest GenMark Diagnostics, Inc seller in Q1 2015 was Visium Asset Management, an estimated $8.78M sold.
Based on aggregated 13F filings for Q1 2015.